Metformin's effect was demonstrated by fewer number of empty osteocyte lacunae, a hallmark of osteonecrosis, fewer apoptotic osteoclasts, and suppression of inflammatory mechanisms, including macrophage infiltration (F4/80) and IL‐1β production. The gene discussed is IL1B; the disease is osteonecrosis.